ClinicalTrials.gg
Not yet recruitingNCT06777459Updated Jan 15, 2025

Study of Nitrate-Rich Juice on Cognitive Function in Heavy Alcohol Drinkers: a Two-Stage Adaptive Design Real-World Clinical Trial

An interventional study of Nitrate-rich beetroot juice in Heavy Drinking, sponsored by Peking University Sixth Hospital. Not yet recruiting. Per ClinicalTrials.gov, last updated 2025-01-15.

Sponsored by Peking University Sixth Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Not applicable
Sex
All
01

Study summary

It is known that alcohol consumption can lead to cognitive impairment and dysregulation of inflammatory responses. A preliminary randomized controlled trial conducted by our research team has suggested that nitrate may improve cognition in hospitalized patients with alcohol dependence. To further expand the population and applicability, this study aims to explore the effects of nitrate on cognition in a real-world population of heavy drinkers. The researchers have designed a two-stage clinical trial: the first stage involves the analysis of existing data, and the second stage will recruit 43-54 new participants for a 14-day dietary inorganic nitrate (nitrate-rich beetroot juice, \~750 mg NO3- /d) intervention.

Read the detailed description

No comments

02

Conditions studied

  • Heavy Drinking

Keywords

  • Heavy Drinking
  • Cognitive Function
  • Nitrate
  • Two-stage adaptive design
  • Real World Study
03

In context

Lead sponsor

Peking University Sixth Hospital is the lead sponsor of 19 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

A. Individuals with a history of heavy alcohol consumption (as defined below), who have continued heavy drinking within the past week and have no plans to quit drinking within the next month.

B. Individuals with a history of heavy alcohol consumption who are currently hospitalized due to alcohol dependence or alcohol use disorder, and are still undergoing treatment.

The CDC (Centers for Disease Control and Prevention) defines heavy alcohol consumption as follows: For males: more than 15 standard alcoholic drinks per week. For females: more than 8 standard alcoholic drinks per week. Here, one standard drink unit is approximately 14 grams of pure alcohol- C. A (MoCA) score greater than 13.

Exclusion criteria

Exclusion Criteria:

A. Individuals with a history of or current infectious diseases. B. Individuals with a history of or current severe cardiovascular, cerebrovascular, hepatic, or renal diseases.

C. Individuals who are allergic to any substances used in the trial, such as beets.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
43 participants (estimated)

Study arms

  • Experimental
    RWS

    Interventions:Dietary Supplement: nitrate-rich beetroot juice

    Dietary Supplement: Nitrate-rich beetroot juice

Interventions

  • Dietary supplementNitrate-rich beetroot juice

    Nitrate-rich beetroot juice, \~750 mg NO3- /d

06

What researchers measure

Primary outcomes

  1. The number of responders with a DMS-PCAD score improvement of 6 or more after intervention compared to baseline

    Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays) The score range is from 0% to 100%, with higher scores indicating better performance in visual memory and matching tasks.

    Time frame: baseline and post-intervention(two weeks after baseline test)

Secondary outcomes

  1. Changes of Spatial Working Memory Between Errors from baseline to post-intervention

    Test by SWM-BE (The Spatial Working Memory Between Errors ) The SWM-BE score range is primarily based on the number of errors, typically ranging from 0 to 10 errors. The higher the score, the fewer the errors, and the better the performance.

    Time frame: baseline and post-intervention(two weeks after baseline test)

  2. Changes of cognitive function from baseline to post-intervention

    Test by Cambridge Neuropsychological Test Automatic Battery,CANTAB

    Time frame: baseline and post-intervention(two weeks after baseline test)

  3. Changes of oral microbiota from baseline to post-intervention

    Saliva samples were used to test the composition of microbiota by 16S RNA sequencing.

    Time frame: baseline and post-intervention(two weeks after baseline test)

  4. Changes of inflammatory factors levels in serum from baseline to post-intervention

    We collected serum sampleWs were used to test the levels of inflammatory factors by Elisa

    Time frame: baseline and post-intervention(two weeks after baseline test)

  5. depression

    Test by Self-Rating Depression Scale

    Time frame: baseline and post-intervention (two weeks after baseline test)

  6. anxiety

    Test by Self-Rating Anxiety Scale

    Time frame: baseline and post-intervention(two weeks after baseline test)

  7. Sleep Quality

    Test by pittsburgh sleep quality index

    Time frame: baseline and post-intervention (two weeks after baseline test)

  8. Cognitive

    Test by Montreal Cognitive Assessment

    Time frame: baseline and post-intervention (two weeks after baseline test)

  9. Dream

    Test by Dream Evaluation Scale

    Time frame: baseline and post-intervention (two weeks after baseline test)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2025; primary completion for Dec 2025, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 7, 2025
First posted
Jan 15, 2025
StartEst.
Jan 15, 2025
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Jan 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06777459
Lead sponsor
Peking University Sixth Hospital
Responsible party
Hongqiang Sun (Vice President of Peking University Sixth Hospital, Peking University Sixth Hospital) — Principal investigator
First posted
Jan 15, 2025
Start date
Jan 15, 2025 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jan 15, 2025

Study contacts

FUYU Song
Contact
songfy@163.com
+8613699266767

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion